Day Three - 08 July 2021

9:00 am - 9:45 am EST Deep Learning approaches in Drug Design

Suneel Kumar BVS - Director of Computational Chemistry, AI, Sai Life Sciences
  • Approaches in Hit identification/generation
  • Introduction and Practises in AI-guided molecular design approaches
  • Case Study on Deep reinforcement learning for de novo drug design using RNN/LSTM


img

Suneel Kumar BVS

Director of Computational Chemistry, AI
Sai Life Sciences

10:00 am - 10:45 am EST FIRESIDE CHAT: Applications of AI in the Discovery of Targets

Paul Nioi - Vice President, Discovery and Translational Research, Alnylam Pharmaceuticals

At Alnylam Pharma we have been working in partnership with the UK Biobank to assess genetic and phenotypic data, biomarker data, MRI scans and medical imaging to understand which genes to go after for a particular disease. We have specific use cases and lessons learned and this fireside chat will discuss:

  • Repurposing technology to train neural network models
  • How to ascertain which genes to go after when scanning data?
  • How can we link this to genetic data?
img

Paul Nioi

Vice President, Discovery and Translational Research
Alnylam Pharmaceuticals

11:00 am - 11:45 am EST JOINT CASE STUDY: Patent Scope Visualization - A Patent Mining and Visualization Platform for Antibody Claims

Peter Henstock - Machine Learning & AI Technical Lead, Pfizer

This session will address:

  • Importance of patents for scientific and legal teams
  • Overview on extracting key epitope data from antibody patents
  • Novel visualization showing the claimed epitopes in context
img

Peter Henstock

Machine Learning & AI Technical Lead
Pfizer